Franklin Resources Inc United Therapeutics Corp Transaction History

Franklin Resources Inc

  • $330 Billion
  • Q1 2025

A detailed history of Franklin Resources Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Franklin Resources Inc holds 244,112 shares of UTHR stock, worth $79.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
244,112
Previous 329,379 25.89%
Holding current value
$79.1 Million
Previous $116 Million 35.25%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$304.42 - $380.78 $26 Million - $32.5 Million
-85,267 Reduced 25.89%
244,112 $75.3 Million
Q4 2024

Feb 12, 2025
BUY
$348.66 - $410.0 $27.4 Million - $32.3 Million
78,660 Added 31.37%
329,379 $116 Million
Q3 2024

Nov 12, 2024
BUY
$311.04 - $363.55 $38.5 Million - $45.1 Million
123,929 Added 97.74%
250,719 $89.8 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $20.1 Million - $28 Million
87,868 Added 225.75%
126,790 $40.4 Million
Q1 2024

May 13, 2024
SELL
$210.76 - $249.51 $2.3 Million - $2.73 Million
-10,929 Reduced 21.92%
38,922 $8.94 Million
Q4 2023

Feb 09, 2024
BUY
$214.88 - $256.94 $8.36 Million - $10 Million
38,915 Added 355.84%
49,851 $11 Million
Q3 2023

Nov 13, 2023
BUY
$211.82 - $248.24 $758,739 - $889,195
3,582 Added 48.71%
10,936 $2.47 Million
Q2 2023

Aug 11, 2023
SELL
$205.19 - $232.99 $734,169 - $833,638
-3,578 Reduced 32.73%
7,354 $1.62 Million
Q1 2023

May 12, 2023
SELL
$212.99 - $276.17 $110,967 - $143,884
-521 Reduced 4.55%
10,932 $2.45 Million
Q4 2022

Feb 10, 2023
BUY
$205.95 - $280.43 $143,135 - $194,898
695 Added 6.46%
11,453 $3.18 Million
Q3 2022

Nov 14, 2022
BUY
$203.3 - $244.17 $409,852 - $492,246
2,016 Added 23.06%
10,758 $2.25 Million
Q2 2022

Aug 11, 2022
BUY
$174.81 - $241.14 $644,174 - $888,600
3,685 Added 72.87%
8,742 $2.06 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $2.82 Million - $3.63 Million
-16,957 Reduced 77.03%
5,057 $909,000
Q4 2021

Feb 11, 2022
BUY
$184.32 - $216.08 $458,588 - $537,607
2,488 Added 12.74%
22,014 $4.76 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $2.67 Million - $3.19 Million
14,853 Added 317.85%
19,526 $3.61 Million
Q2 2021

Aug 13, 2021
SELL
$170.47 - $211.93 $1.07 Million - $1.33 Million
-6,260 Reduced 57.26%
4,673 $838,000
Q1 2021

May 13, 2021
SELL
$153.94 - $174.85 $1.66 Million - $1.88 Million
-10,755 Reduced 49.59%
10,933 $1.83 Million
Q4 2020

Feb 10, 2021
BUY
$101.87 - $151.79 $112,158 - $167,120
1,101 Added 5.35%
21,688 $3.29 Million
Q3 2020

Nov 12, 2020
BUY
$99.9 - $121.13 $2.06 Million - $2.49 Million
20,587 New
20,587 $2.08 Million
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $2.21 Million - $2.54 Million
-29,566 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$76.06 - $120.81 $512,035 - $813,292
6,732 Added 29.48%
29,566 $2.31 Million
Q1 2019

May 14, 2019
BUY
$107.15 - $126.84 $528,356 - $625,448
4,931 Added 27.54%
22,834 $2.68 Million
Q4 2018

Feb 12, 2019
BUY
$101.4 - $128.73 $141,047 - $179,063
1,391 Added 8.42%
17,903 $1.95 Million
Q3 2018

Nov 13, 2018
BUY
$113.81 - $129.46 $260,966 - $296,851
2,293 Added 16.13%
16,512 $2.11 Million
Q2 2018

Aug 14, 2018
BUY
$101.14 - $118.31 $409,718 - $479,273
4,051 Added 39.84%
14,219 $1.61 Million
Q1 2018

May 10, 2018
BUY
$107.21 - $151.94 $137,228 - $194,483
1,280 Added 14.4%
10,168 $1.14 Million
Q4 2017

Feb 14, 2018
BUY
$118.58 - $151.28 $520,447 - $663,967
4,389 Added 97.56%
8,888 $1.32 Million
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $515,585 - $615,508
4,499
4,499 $528,000

Others Institutions Holding UTHR

# of Institutions
733
Shares Held
43.6M
Call Options Held
124K
Put Options Held
122K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email